TITLE

Anastrozole had a better risk-benefit profile than tamoxifen as adjuvant treatment for breast cancer in postmenpausal women

AUTHOR(S)
Hillner, Bruce E.
PUB. DATE
January 2007
SOURCE
ACP Journal Club;Jan/Feb2007, Vol. 146 Issue 1, p4
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article cites a study on the use of anastrozole and tamoxifen as adjuvant treatment by postmenopausal women in the early stages of breast cancer. The study was conducted by researcher A. Buzdar and colleagues, and was published in an issue of the journal "The Lancet Oncology." The study reported that women taking anastrozole were less likely to have treatment-related adverse events. The study also showed that the women taking tamoxifen were more prone to side effects.
ACCESSION #
23847334

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics